Evobrutinib pathway to its major metabolite M463-2 and insights from a biotransformation and DDI perspective.
Scheible H, Schieferstein H, Schmidt R, Pusecker K, Gradhand U, Gopalakrishnan S, Iqbal K, Dong J, Jones R, Meli C, Bolleddula J, Dyroff M, Georgi K.
Scheible H, et al. Among authors: dong j.
Xenobiotica. 2023 Dec;53(8-9):547-558. doi: 10.1080/00498254.2023.2272180. Epub 2023 Nov 26.
Xenobiotica. 2023.
PMID: 37880944
Free article.